Phase 3 Trial Data Supports Efficacy of Novel Treatment for ADHD in Adults
CONFERENCE REPORTER: Investigators found in recent research that centanafadine sustained release is an effective treatment for adults with attention-deficit/hyperactivity disorder (ADHD) regardless of patient treatment history. They shared these results in a poster presentation at the 2024 American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting.
Other Articles in this Edition
Phase 3 Trial Data Supports Efficacy of Novel Treatment for ADHD in Adults
Unique Motivations and Patters (sic) of Substance Use in Individuals With ADHD
No, You Don’t Have Adult ADHD. You’re Probably Just Distracted.
Pediatric Bipolar Disorder and ADHD Have Shared Neural Substrate Alterations
Sleep Disorders Differ for Autism, ADHD Versus Typical Development
Shortage of ADHD drugs continues as patients scramble to find medication
Women are being diagnosed with ADHD at unprecedented rates. Here’s why.
Expert panelists call for more research on ADHD in women, girls
University of Alabama to hold regional ADHD conference
Global Prevalence of Mental Health Disorders Among Patients With Atopic Dermatitis